Liraglutide suppresses the proliferation of endometrial cancer cells through the adenosine 5'-monophosphate (AMP)-activated protein kinase signaling pathway.
10.1097/CM9.0000000000001363
- Author:
Xin-Xin ZHU
1
;
Zong-Hao FENG
2
;
Lin-Zhi LIU
1
;
Yan ZHANG
1
Author Information
1. Department of Obstetrics and Gynecology, Peking University First Hospital, Beijing 100034, China.
2. Department of Obstetrics and Gynecology, Beijing Tsinghua Changgung Hospital, Beijing 102218, China.
- Publication Type:Journal Article
- MeSH:
AMP-Activated Protein Kinases/metabolism*;
Adenosine;
Adenosine Monophosphate;
Cell Proliferation;
Endometrial Neoplasms/drug therapy*;
Female;
Humans;
Liraglutide;
Phosphorylation;
Protein Kinases;
Signal Transduction
- From:
Chinese Medical Journal
2021;134(5):576-578
- CountryChina
- Language:English
